News

Harrow Partners with Leading Healthcare Market Access Technology Platforms

Agreements Support the Upcoming Launch of VEVYE®NASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that…

3 months ago

Carebox and Gastric Cancer Foundation (GCF) Announce the GCF Clinical Trial Finder

Now patients, caregivers and healthcare professionals have an easy and effective way to search for and match with gastric cancer…

3 months ago

Introducing PillSafe(R), the New ‘Smart’ Pill Bottle for Prescription Medication

PillSafe® protects the patient with a patented, innovative pill distribution control system that improves dosage safety, prevents prescription drug misuse,…

3 months ago

OneMedNet iRWD(TM) Now Available on AWS Data Exchange

~ AWS Increases Life Sciences Accessibility to Industry Leading Regulatory-Grade Imaging Real World Data Platform ~MINNEAPOLIS, MN / ACCESSWIRE /…

3 months ago

Protagonist Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

NEWARK, CA / ACCESSWIRE / January 3, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh…

3 months ago

Assertio Holdings, Inc. Announces Leadership Transition

Dan Peisert Stepping Down as CEO Board member Heather Mason Appointed Interim CEO LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE…

3 months ago

Cannabix Technologies Files Patent for Proprietary Laboratory Drug Analysis Device

Fig. 1 Cannabix “MS Breath Sampler (MSBS)” technology coupled with Thermo TSQ Ultra Fig. 2 Cannabix updated Breath Collection Unit…

3 months ago

Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with…

3 months ago

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that…

3 months ago

NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University

Scorpius subsidiary to manufacture novel biologic targeting substance use disorderDURHAM, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE…

3 months ago